SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-24-017544
Filing Date
2024-02-27
Accepted
2024-02-27 16:31:17
Documents
17
Period of Report
2023-12-15
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO FORM 8-K ea0200807-8ka2_onconetix.htm   iXBRL 8-K/A 31999
2 AUDITED FINANCIAL STATEMENTS OF PROTEOMEDIX FOR THE FISCAL YEARS ENDED DECEMBER ea0200807ex99-1_onconetix.htm EX-99.1 298988
3 UNAUDITED FINANCIAL STATEMENTS OF PROTEOMEDIX FOR THE NINE MONTHS ENDED SEPTEMBE ea0200807ex99-2_onconetix.htm EX-99.2 205033
4 UNAUDITED PRO-FORMA CONSOLIDATED FINANCIAL INFORMATION OF THE COMPANY AND PROTEO ea0200807ex99-3_onconetix.htm EX-99.3 177267
  Complete submission text file 0001213900-24-017544.txt   982693

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE onco-20231215.xsd EX-101.SCH 3042
6 XBRL LABEL FILE onco-20231215_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE onco-20231215_pre.xml EX-101.PRE 22377
18 EXTRACTED XBRL INSTANCE DOCUMENT ea0200807-8ka2_onconetix_htm.xml XML 4747
Mailing Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202
Business Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202 513-620-4101
Onconetix, Inc. (Filer) CIK: 0001782107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-41294 | Film No.: 24687415
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)